Home

Sandu Pharmaceuticals Ltd Quarterly Result

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

Net Profit - Last Quarter

₹ 0.5 Cr.

Last updated on: Apr 03, 2025

Sandu Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Sandu Pharmaceuticals Ltd for the Sep '24 is ₹ 17.73 crore as compare to the Jun '24 revenue of ₹ 17.09 crore.
  • This represent the growth of 3.74%a1# The ebitda of Sandu Pharmaceuticals Ltd for the Sep '24 is ₹ 0.94 crore as compare to the Jun '24 ebitda of ₹ 0.45 crore.
  • This represent the growth of 108.89%a1# The net profit of Sandu Pharmaceuticals Ltd for the Sep '24 is ₹ 0.5 crore as compare to the Jun '24 net profit of ₹ 0.17 crore.
  • This represent the growth of 194.12%a1#.

Sandu Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Sandu Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Sandu Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Apr 202550
01 Apr 202550
28 Mar 202548.99
27 Mar 202546.23
26 Mar 202549.19
25 Mar 202550.22
24 Mar 202551.8
21 Mar 202552.69
20 Mar 202551.47
19 Mar 202551.99

Historical Revenue of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Sandu Pharmaceuticals Ltd News Hub

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be he

Read more

13 Aug 24

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12

Read more

13 Aug 24

Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as a

Read more

13 Aug 24

Sandu Pharmaceuticals schedules board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2024

Read more

06 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Sandu Pharmaceuticals Ltd

What key financial metrics are included in Sandu Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Sandu Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Sandu Pharmaceuticals Ltd announce its quarterly results?

Sandu Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Sandu Pharmaceuticals Ltd's quarterly performance impact its stock price?

Sandu Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Sandu Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Sandu Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Sandu Pharmaceuticals Ltd's quarterly results?

Yes, Sandu Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions